Published date: Dec 27 2024

Journal Title: Dubai Medical Journal

Issue title: Dubai Medical Journal (DMJ): Volume 7 Issue 4

Pages: 340 - 344

DOI: 10.18502/dmj.v7i4.17807

Sara Anibars.anibar@uiz.ac.maNephrology Department, Souss Massa University Hospital, Faculty of Medicine, Ibn Zohr University, Agadir

Ihsene CherradiNephrology Department, Souss Massa University Hospital, Faculty of Medicine, Ibn Zohr University, Agadir

Mohammed BouchoualNephrology Department, Souss Massa University Hospital, Faculty of Medicine, Ibn Zohr University, Agadir

Marouane JabraneNephrology Department, Souss Massa University Hospital, Faculty of Medicine, Ibn Zohr University, Agadir

Mohamed ArrayhaniNephrology Department, Souss Massa University Hospital, Faculty of Medicine, Ibn Zohr University, Agadir

Introduction: It has been suggested that patients with autoimmune diseases are more likely to develop other malignancies. However, the association between lupus and multiple myeloma (MM) is still not much described in the literature.

Case Report: We report the observation of a 46-year-old female patient, in premenopause, in whom the diagnosis of systemic lupus was retained (SLICC criteria 7) with cutaneous, joint, hematological, immunological, and renal involvement. The discovery of MM was suspected due to a peak in gamma globulins on plasma protein electrophoresis and confirmed by myelogram. The outcome was fatal due to septic shock before starting any immunosuppression.

Discussion and Conclusion: In this literature review, 15 cases are reported on the occurrence of MM years after the diagnosis of lupus, only two cases were like our observation with a concomitant diagnosis of the 2 diseases. The management is still not codified; hence the prognosis of this association remains reserved, encouraging early detection of malignant plasma cell proliferation.

Keywords: multiple myeloma, systemic lupus, concomitant, diagnostic

[1] Zucchi D, Silvagni E, Elefante E, Signorini V, Cardelli C, Trentin F, et al. Systemic lupus erythematosus: One year in review 2023. Clin Exp Rheumatol. 2023 May;41(5):997–1008.

[2] Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus. 2007;16(6):426–429.

[3] Nandakumar KS, Nündel K. Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models. Front Immunol. 2022 Dec;13:1118180.

[4] Maamar M, Tazi Mezalek Z, Harmouche H, Adnaoui M, Aouni M, Maaouni A. Systemic lupus erythematosus and multiple myeloma: An uncommon association. Two cases and literature review. Clin Exp Rheumatol. 2008;26(4):667–670.

[5] Choi JW, Han SW, Kwon KT, Kim GW. Early onset multiple myeloma in a patient with systemic lupus erythematosus: A case report and literature review. Clin Rheumatol. 2010 Nov;29(11):1323–1326.

[6] Lian L, Wang K, Xu S. Systemic lupus erythematosus associated with multiple myeloma: Two case reports and a literature review. Immun Inflamm Dis. 2023 Jan;11(1):e755.

[7] Bachir H, Harmouche H, Maamar M, Adnaoui M, Aouni M, Tazi Mezalek Z. Myélome multiple associé à un lupus érythémateux systémique: Trois cas. Rev Med Interne. 2013;34:A121.

[8] Bouatay A, Hizem, S, Youssef Y, Sayari F, Jmili N, Abderrahim K, Kortas M. Myélome multiple : Aspect clinique, diagnostic biologique et pronostic. Immuno-analyse & Biologie Spécialisée. 2013;28:30–35.

[9] Desai R, Devaragudi S, Kaur L, Singh K, Bawa J, Theik NW, et al. SLE and multiple myeloma: An underlooked link? A review of case reports from the last decade. J Med Life. 2024 Feb;17(2):141–146.